Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Capricorn Systems Global Solutions Ltd

CAPRICORN
BSE
11.56
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Capricorn Systems Global Solutions Ltd

CAPRICORN
BSE
11.56
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
32Cr
Close
Close Price
11.56
Industry
Industry
IT - Software
PE
Price To Earnings
PS
Price To Sales
2.52
Revenue
Revenue
13Cr
Rev Gr TTM
Revenue Growth TTM
1,194.95%
PAT Gr TTM
PAT Growth TTM
-91.01%
Peer Comparison
How does CAPRICORN stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
CAPRICORN
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
0000000000012
Growth YoY
Revenue Growth YoY%
0.0-58.1-35.3-24.2-17.984.618.24.08.712.511.54,519.2
Expenses
ExpensesCr
0000011000012
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
7.1-61.59.1-36.00.0-175.0-161.5-19.2-4.0-37.03.50.3
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
0.0-900.0200.0-325.0-100.0-425.0-2,200.044.476.2102.4160.0
NPM
NPM%
3.6-61.59.1-36.00.0-175.0-161.5-19.2-8.0-37.03.50.3
EPS
EPS
0.0-0.10.0-0.10.0-0.6-0.6-0.10.0-0.10.00.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
4454421111113
Growth
Revenue Growth%
-4.35.018.9-27.13.7-46.3-33.70.1-0.2-37.121.51,171.7
Expenses
ExpensesCr
4453422111213
Operating Profit
Operating ProfitCr
0000000000-10
OPM
OPM%
6.25.13.12.30.33.0-32.54.64.6-19.0-89.8-0.6
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
0000000000-10
Tax
TaxCr
000000000000
PAT
PATCr
0000000000-10
Growth
PAT Growth%
42.0-12.6-42.3-58.0-130.8505.2-1,691.8111.012.1-372.4-518.791.2
NPM
NPM%
2.62.21.10.6-0.21.4-33.13.64.1-17.7-90.3-0.6
EPS
EPS
0.30.10.10.1-1.9-0.1-0.60.10.1-0.2-1.3-0.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
444444444444
Reserves
ReservesCr
111100-1000-1-1
Current Liabilities
Current LiabilitiesCr
121100000011
Non Current Liabilities
Non Current LiabilitiesCr
000000000000
Total Liabilities
Total LiabilitiesCr
777644444434
Current Assets
Current AssetsCr
122211111100
Non Current Assets
Non Current AssetsCr
555433333333
Total Assets
Total AssetsCr
777644444434

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
00011000000
Investing Cash Flow
Investing Cash FlowCr
00000000000
Financing Cash Flow
Financing Cash FlowCr
000-1-1000000
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
00011000000
CFO To PAT
CFO To PAT%
285.815.7-77.42,460.4-9,708.4385.26.5708.9-242.4191.93.6
CFO To EBITDA
CFO To EBITDA%
121.96.8-26.9652.46,348.9179.16.7559.8-214.3178.83.6

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2112702434446
Price To Earnings
Price To Earnings
200.0134.8143.80.00.0130.10.091.780.10.00.0
Price To Sales
Price To Sales
5.33.01.50.00.61.82.43.33.45.36.4
Price To Book
Price To Book
3.82.31.40.00.50.90.91.21.21.22.4
EV To EBITDA
EV To EBITDA
88.463.054.94.5178.856.2-6.761.564.8-26.2-7.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
OPM
OPM%
6.25.13.12.30.33.0-32.54.64.6-19.0-89.8
NPM
NPM%
2.62.21.10.6-0.21.4-33.13.64.1-17.7-90.3
ROCE
ROCE%
2.52.11.22.81.61.3-12.42.01.9-4.1-32.9
ROE
ROE%
1.91.71.00.4-0.20.7-12.51.31.4-4.0-33.0
ROA
ROA%
1.51.30.80.3-0.20.6-11.51.11.3-3.9-27.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Capricorn Systems Global Solutions Limited is currently executing a high-stakes strategic transformation. Historically a niche provider of **Software Services** and **IT-enabled solutions** for the **United States** market, the company is pivoting toward a diversified model centered on **Large-scale Commodity Trading** and **Industrial Manufacturing**. This transition is being formalized through a major amalgamation with **Radical Bio-Organics Limited**, a move designed to scale the balance sheet and enter the high-margin distillery and bio-organics sector. --- ### **The Strategic Pivot: From Legacy IT to Industrial Diversification** The company is moving away from its low-capital, project-based IT roots toward a capital-intensive, high-volume trading and manufacturing framework. * **Amalgamation with Radical Bio-Organics Limited:** This is the cornerstone of the company’s future. The merger integrates a high-turnover manufacturing entity into the listed Capricorn entity. * **New Business Verticals:** In **September 2025**, the company formally amended its Object Clause to authorize the trading, supply, and distribution of: * **Agricultural Commodities:** Rice (broken/whole), wheat, pulses, oilseeds, and food grains. * **Industrial Commodities:** Coal, granite, husk, and minerals. * **Chemicals & Oils:** Edible/non-edible oils (palm, soybean, sunflower) and food additives. * **Manufacturing Entry:** Post-merger, the company will produce **Extra Neutral Alcohol (ENA)**, **Impure Spirit (IS)**, **Dried Distiller Grain with Soluble (DDGS)**, and **Solid Carbon Dioxide ($\text{CO}_2$)**. --- ### **Comparative Scale: Transferee vs. Transferor** The following table illustrates the significant scale-up the company will undergo upon the completion of the merger (data as of **February 2026**): | Particulars | Capricorn Systems (Transferee) | Radical Bio-Organics (Transferor) | | :--- | :--- | :--- | | **Turnover** | **Rs. 20.74 Crore** | **Rs. 451.86 Crore** | | **Total Assets** | **Rs. 28.78 Crore** | **Rs. 225.87 Crore** | | **Net Worth** | **Rs. 26.33 Crore** | **Rs. 71.80 Crore** | | **Share Exchange Ratio** | **1:1** | (1 share of Capricorn for 1 of Radical) | --- ### **Operational Framework & Logistics Model** To manage the transition into physical commodities without excessive overhead, the company has adopted a lean operational strategy: * **"Bill-to-Ship" Model:** Trading operations utilize a direct dispatch system from the point of procurement to the purchaser, minimizing capital-intensive inventory requirements. * **Strategic Warehousing:** While the "bill-to-ship" model is preferred, the company maintains owned or leased warehouses (including pre-fabricated buildings) specifically for **Rice** inventory to manage moisture content and the essential maturing process. * **Indigenous Technology:** The legacy IT segment operates on **100% indigenous technology** with **zero technology imports** over the last **five years**. * **R&D Focus:** An in-house team focuses on the **upgradation and development** of existing tech products to support automated production and real-time market data analysis for the new trading arms. --- ### **Capital Raising & Financial Restructuring** The company has aggressively expanded its capital base to fund the working capital requirements of its new high-volume trading business. * **Rights Issue (Feb 2025):** Allotted **2,39,76,000** shares at **₹10** per share (Ratio **6:1**), raising gross proceeds of **₹2,397.60 lakhs**. * **Preferential Warrants (Apr 2025):** Issued **1,70,00,000** warrants at **₹14.71** per warrant, totaling **₹20.01 Crore** for capital expenditure. * **Authorized Capital Expansion:** Increased from **₹5 Crore** to **₹32 Crore** by **August 2025**. * **Investment Limits:** Approved Section 186 limits up to **₹500 Crore** for future loans and investments. **Projected Working Capital Allocation (FY 2025-26):** | Component | Projected Amount (₹ in Lakhs) | | :--- | :--- | | **Inventory** | **750.00** | | **Advances to Suppliers** | **850.00** | | **Trade Receivables** | **600.00** | | **Total Working Capital Requirement** | **1,800.00** | --- ### **Historical Financial Performance & Liquidity** The company’s financials reflect the "growing pains" of a major pivot, characterized by rising operational costs and a temporary dip in profitability. | Metric (₹ in Lakhs) | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | :--- | | **Total Revenue** | **100.81** | **82.97** | - | | **Net Profit / (Loss)** | **(91.11)** | **(15.10)** | - | | **Net Worth** | **276.00** | **367.00** | - | | **Debt/Institutional Finance** | **Nil** | **Nil** | **Nil** | * **Revenue Volatility:** A **37.10% decline** in FY 2024 was followed by a **21.50% recovery** in FY 2025. * **Working Capital Deficit:** As of March 2025, the legacy business reported **negative net working capital of (321.16)**, which the recent Rights Issue is intended to rectify. * **Zero Debt:** Historically, the company has operated with **zero bank or institutional finance**, relying entirely on own funds and equity raises. --- ### **Risk Matrix & Mitigation Factors** Investors should consider the following risks associated with the company’s new direction: * **Commodity Price & Inventory Risk:** Vulnerability to fluctuations between **paddy procurement** and the sale of **aged rice**. Sub-optimal storage can lead to moisture damage and product rejection. * **Revenue Concentration:** A significant portion of legacy IT revenue is derived from a **single foreign client**, making the company sensitive to that client's stability. * **Foreign Exchange Exposure:** Significant exposure to **Rupee-USD fluctuations** impacts export revenues; the company currently lacks a robust hedging mechanism. * **Promoter Dilution:** Promoters have indicated they will **not subscribe** to their **Rights Entitlements**, which will lead to a dilution of their shareholding and voting power. * **Regulatory Hurdles:** The company is navigating the financial impact of **New Labour Codes** (notified Nov 2025), which have already increased **employee benefit expenses**. --- ### **Future Outlook & Growth Targets** Management’s primary objective is a **re-rating of shares** through increased scale and improved financial visibility. * **Revenue Target:** The company projects a turnover of **₹60 Crore** from the commodities trading vertical alone for **FY 2025-26**. * **Operational Synergies:** The merger is expected to yield cost efficiencies through **bulk procurement** and the rationalization of shared functions (Finance, HR, and IT). * **Market Positioning:** By combining Radical Bio-Organics' manufacturing with Capricorn’s trading expertise, the entity aims to attract a broader **institutional investor base** and improve **share liquidity**.